These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 24687381)

  • 1. Associations of VEGF and VEGFR2 polymorphisms with increased risk and aggressiveness of multiple myeloma.
    Brito AB; Lourenço GJ; Oliveira GB; De Souza CA; Vassallo J; Lima CS
    Ann Hematol; 2014 Aug; 93(8):1363-9. PubMed ID: 24687381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined effect of vascular endothelial growth factor and its receptor polymorphisms in endometriosis: a case-control study.
    Cardoso JV; Abrão MS; Vianna-Jorge R; Ferrari R; Berardo PT; Machado DE; Perini JA
    Eur J Obstet Gynecol Reprod Biol; 2017 Feb; 209():25-33. PubMed ID: 27836223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of single nucleotide variants in
    Assis-Mendonça GR; Campos LG; Delamain MT; de Brito ABC; Fanelli MF; Soares FA; de Souza CA; Vassallo J; Lima CSP
    Leuk Lymphoma; 2023 Dec; 64(13):2165-2177. PubMed ID: 37647140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of VEGF and KDR single nucleotide polymorphisms with colorectal cancer susceptibility in Koreans.
    Jang MJ; Jeon YJ; Kim JW; Cho YK; Lee SK; Hwang SG; Oh D; Kim NK
    Mol Carcinog; 2013 Nov; 52 Suppl 1():E60-9. PubMed ID: 23169005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of single nucleotide polymorphisms in the vascular endothelial growth factor gene with the characteristics and prognosis of renal cell carcinomas.
    Kawai Y; Sakano S; Korenaga Y; Eguchi S; Naito K
    Eur Urol; 2007 Oct; 52(4):1147-55. PubMed ID: 17287073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of
    Vasconcelos VCA; Lourenço GJ; Brito ABC; Vasconcelos VL; Maldaun MVC; Tedeschi H; Marie SKN; Shinjo SMO; Lima CSP
    Tumour Biol; 2019 Sep; 41(9):1010428319872092. PubMed ID: 31486713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor ‑634G/C polymorphism is associated with increased breast cancer risk and aggressiveness.
    Sa-Nguanraksa D; Chuangsuwanich T; Pongpruttipan T; Kummalue T; Rojananin S; Ratanawichhitrasin A; Prasarttong-Osoth P; Chuthatisith S; Pisarnturakit P; Aeumrithaicharoenchok W; Rushatamukayanunt P; Lohsiriwat V; Boonsripitayanon M; Malasit P; O-Charoenrat P
    Mol Med Rep; 2013 Oct; 8(4):1242-50. PubMed ID: 23904001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of vascular endothelial growth factor single nucleotide polymorphisms on the prognosis of breast cancer patients.
    Rani J; Rahul B; Ramesh G; Krishnamoorthy L; Shilpa C; Ramaswamy G; Deshmane V
    Indian J Cancer; 2014; 51(4):512-7. PubMed ID: 26842181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical relevance of vascular endothelial growth factor type A (VEGFA) and VEGF receptor type 2 (VEGFR2) gene polymorphism in chronic lymphocytic leukemia.
    Góra-Tybor J; Szemraj J; Robak T; Jamroziak K
    Blood Cells Mol Dis; 2015 Feb; 54(2):139-43. PubMed ID: 25488616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene polymorphisms of VEGF and VEGFR2 are associated with the severity of Hashimoto's disease and the intractability of Graves' disease, respectively.
    Okamoto M; Watanabe M; Inoue N; Ogawa K; Hidaka Y; Iwatani Y
    Endocr J; 2020 May; 67(5):545-559. PubMed ID: 32074519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of vascular endothelial growth factor gene polymorphisms in patients with colorectal cancer.
    Jang MJ; Kim JW; Jeon YJ; Chong SY; Oh D; Kim NK
    Int J Clin Oncol; 2013 Dec; 18(6):1032-41. PubMed ID: 23132736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Vascular Endothelial Growth Factor A (VEGFA) and its Receptor (VEGFR2) Gene Polymorphisms with Risk of Chronic Myeloid Leukemia and Influence on Clinical Outcome.
    Lakkireddy S; Aula S; Kapley A; Swamy AV; Digumarti RR; Kutala VK; Jamil K
    Mol Diagn Ther; 2016 Feb; 20(1):33-44. PubMed ID: 26476544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Association of single nucleotide polymorphisms in VEGF gene with the risk of endometriosis and adenomyosis].
    Liu Q; Li Y; Zhao J; Zhou RM; Wang N; Sun DL; Duan YN; Kang S
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Apr; 26(2):165-9. PubMed ID: 19350508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms in vascular endothelial growth factor receptor 2 are associated with better response rates to ranibizumab treatment in age-related macular degeneration.
    Hermann MM; van Asten F; Muether PS; Smailhodzic D; Lichtner P; Hoyng CB; Kirchhof B; Grefkes C; den Hollander AI; Fauser S
    Ophthalmology; 2014 Apr; 121(4):905-10. PubMed ID: 24365177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germline Polymorphisms of the VEGF Pathway Predict Recurrence in Nonadvanced Differentiated Thyroid Cancer.
    Marotta V; Sciammarella C; Capasso M; Testori A; Pivonello C; Chiofalo MG; Gambardella C; Grasso M; Antonino A; Annunziata A; Macchia PE; Pivonello R; Santini L; Botti G; Losito S; Pezzullo L; Colao A; Faggiano A
    J Clin Endocrinol Metab; 2017 Feb; 102(2):661-671. PubMed ID: 27849428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial growth factor (VEGF) gene polymorphisms and colorectal cancer: a meta-analysis of epidemiologic studies.
    Zhao Z; Ba C; Wang W; Wang X; Xue R; Wu X
    Genet Test Mol Biomarkers; 2012 Dec; 16(12):1390-4. PubMed ID: 23005896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carfilzomib and lenalidomide response related to VEGF and VEGFR2 germline polymorphisms.
    Sissung TM; Peer CJ; Korde N; Mailankody S; Kazandjian D; Venzon DJ; Landgren O; Figg WD
    Cancer Chemother Pharmacol; 2017 Jul; 80(1):217-221. PubMed ID: 28488026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis.
    Jin Q; Hemminki K; Enquist K; Lenner P; Grzybowska E; Klaes R; Henriksson R; Chen B; Pamula J; Pekala W; Zientek H; Rogozinska-Szczepka J; Utracka-Hutka B; Hallmans G; Försti A
    Clin Cancer Res; 2005 May; 11(10):3647-53. PubMed ID: 15897560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of vascular endothelial growth factor in non‑small cell lung cancer pathogenesis.
    Krupnova EV; Shapetska MN; Mikhalenko EP; Chebotaryova NV; Shchayuk AN; Pissarchik SN; Prokhorov AV
    Exp Oncol; 2015 Sep; 37(3):213-7. PubMed ID: 26422107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FGF9-induced ovarian cancer cell invasion involves VEGF-A/VEGFR2 augmentation by virtue of ETS1 upregulation and metabolic reprogramming.
    Bhattacharya R; Ray Chaudhuri S; Roy SS
    J Cell Biochem; 2018 Nov; 119(10):8174-8189. PubMed ID: 29904943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.